Roche Q3 financials
This article was originally published in The Tan Sheet
Executive Summary
Swiss firm is setting aside approximately $808.8 mil. ($1=CHF 1.48) to settle ongoing vitamin price-fixing litigation, execs state during Oct. 10 conference call. "Over the last few weeks, we have made considerable progress in resolving major cases in the U.S. and elsewhere," company says. Vitamins & Fine Chemicals segment experienced 5% sales decline in Q3, but "sales volume grew significantly," Roche reports. Division's sale to DSM is "on track" to close in Q1 2003, firm says (1"The Tan Sheet" Sept. 9, 2002, p. 6)...
You may also be interested in...
DSM To Acquire Leading Position In Vitamin Supply Market With Roche Deal
Dutch life sciences and performance materials producer DSM will enter the vitamin and carotenoid supply business at the top with the planned acquisition of Roche's Vitamins and Fine Chemicals division
Cosmetic And Personal Care Trademark Review: 16 April
Personal care and cosmetic product trademark filings compiled from the Official Gazette of the US Patent and Trademark Office, Class 3.
Health And Wellness Weekly Trademarks Review: 16 April
Trademarks are registered and published for opposition with the US Patent and Trademark Office and are published weekly in the agency's Official Gazette.